INCREASED HEPARIN-RELEASABLE PLATELET FACTOR-4 AND D-DIMER IN PATIENTS ONE-MONTH AFTER THE ONSET OF ACUTE MYOCARDIAL-INFARCTION - PERSISTENT ACTIVATION OF PLATELETS AND THE COAGULATION FIBRINOLYTIC SYSTEM

Citation
S. Abe et al., INCREASED HEPARIN-RELEASABLE PLATELET FACTOR-4 AND D-DIMER IN PATIENTS ONE-MONTH AFTER THE ONSET OF ACUTE MYOCARDIAL-INFARCTION - PERSISTENT ACTIVATION OF PLATELETS AND THE COAGULATION FIBRINOLYTIC SYSTEM, International journal of cardiology, 47(1), 1994, pp. 7-12
Citations number
20
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
01675273
Volume
47
Issue
1
Year of publication
1994
Supplement
S
Pages
7 - 12
Database
ISI
SICI code
0167-5273(1994)47:1<7:IHPFAD>2.0.ZU;2-Q
Abstract
To evaluate the activity of platelets and the coagulation/fibrinolytic system 1 month after the onset of acute myocardial infarction, we mea sured the plasma levels of molecular markers, i.e. beta-thromboglobuli n, platelet factor 4, thrombin-antithrombin III complex and D dimer, i n 16 patients with acute myocardial infarction and in 11 normal subjec ts. Blood was drawn through a catheter placed in the pulmonary artery before heparin injection. The heparin-releasable platelet factor 4 was calculated by subtracting the level before the injection of 5000 U of heparin, from the level 5 min after injection. The plasma beta-thromb oglobulin, thrombin-antithrombin III complex and the D dimer levels in the acute phase of myocardial infarction were 134.9 +/- 121.2, 11.2 /- 7.1 and 164.4 +/- 115.3 ng/ml, respectively. These values were sign ificantly higher than those in the normal subjects. The plasma levels of beta-thromboglobulin and thrombin-antithrombin III complex, 1 month after the onset (36.6 +/- 16.4 and 4.6 +/- 2.3 ng/ml, respectively) w ere not significantly different from those of the normal subjects. In contrast, D dimer and heparin-releasable platelet factor 4 were 216.9 +/- 176.9 and 80.5 +/- 29.3 ng/ml, respectively, and significantly hig her than in the normal subjects. These findings suggest a latent but p ersistent activation of the platelets and the coagulation/fibrinolytic system 1 month after the onset of acute myocardial infarction.